PURA Grows CBD Rollup Revenue Potential Advancing Acquisition Into $6.9 B Market
March 03 2020 - 12:54PM
InvestorsHub NewsWire
PURA Grows CBD Rollup Revenue
Potential Advancing Acquisition Into $6.9 B Market
Dallas, TX -- March 3, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced continuing to move forward with
the previously announced acquisition of a CBD Confections
operation. Earlier today PURA reported that the fairness
opinion on the target CBD Confections acquisition coming from a
third-party analyst is expected to be complete next week. The
fairness opinion has been undertaken as one of the conditions of
the agreed acquisition terms between PURA and the seller.
PURA expects the acquisition of the CBD Confections operation to
close soon after the completion of the fairness opinion. The
CBD Infused Confections operation is
currently producing CBD Infused Gummies and CBD Infused Gum. The
CBD Infused Gummies market alone is anticipated to
reach $6.9
Billion by 2025.
PURA recently launched a campaign to
acquire CBD infused beverage, edible and topical operations and
also announced closing on a $5 million investment to fund the
acquisition campaign. The $5 million investment is structured as a
debt facility whereby funds can be drawn as needed to fund
acquisitions. The drawn funds would be secured by the
acquired asset and the debt can be repaid in stock at $0.10 per
share.
PURA last week announced the acquisition
of a CBD Infused Pet Products operation. The seller currently
provides concierge pet services through an online portal and the
CBD Infused Pet Product Line will bear the name of the
portal. PURA will have access to the portal and the existing
customer base in conjunction with the purchase agreement.
The CBD pet products market is
anticipated to reach $1.16 billion in
the U.S. alone by 2022
PURA is currently working to build a
pipeline of more acquisition
opportunities.
The CBD Confections seller is
Kali-Extracts, Inc. (USOTC:
KALY). The CBD Confections are called Hemp4mula
and are currently available for sale on www.USMJ.com (https://usmj.com/collections/cbd) from
North American Cannabis Holdings, Inc. (USOTC:
USMJ).
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024